e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
The impact of the organisation of care on costs: the role of the physician in home care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Stepping up the controller medication in asthma patients: Impact of various treatment options on costs
M. Sadatsafavi, P. Bedouch, M. FitzGerald, C. Narra, L. Lynd (Vancouver, Canada)
Source:
Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care
Session:
The impact of the organisation of care on costs: the role of the physician in home care
Session type:
Oral Presentation
Number:
4681
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sadatsafavi, P. Bedouch, M. FitzGerald, C. Narra, L. Lynd (Vancouver, Canada). Stepping up the controller medication in asthma patients: Impact of various treatment options on costs. Eur Respir J 2011; 38: Suppl. 55, 4681
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Initiation of controller medication in newly diagnosed asthma patients: Impact on economic resource utilization
Source: Annual Congress 2011 - New insights in the incidence, variation and risk factors of asthma
Year: 2011
Impact of add-on medications on patient‘s satisfaction in patients with asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 273s
Year: 2005
Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004
Adherence to asthma medication and preferences for once-daily treatment: Importance of treatment intrusiveness and patient beliefs
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
In whom should regular asthma controller therapy be initiated?
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Real-life asthma impairment: SABA use depends on smoking phenotype
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013
Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019
Modelling cost effectiveness of a COPD pathway using the Star approach; could cognitive behavioural therapy (CBT) be cost effective in preventing panic-associated admissions?
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016
Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021
Symptom pattern and treatment for people non-compliant with asthma medication
Source: Annual Congress 2005 - Allergic rhinitis and asthma in primary care
Year: 2005
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
Improving adherence to asthma medications: same-old, same-old?
Source: Eur Respir J, 57 (6) 2004284; 10.1183/13993003.04284-2020
Year: 2021
Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Rescue/acute and allergy medication use among children on asthma controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 378s
Year: 2004
Impact of home hospitalization on treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 207s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept